Bio-Techne (TECH) Liabilities from Discontinued Operations (2023 - 2024)
Bio-Techne's (TECH) quarterly Liabilities from Discontinued Operations came in at 689000.0 in Q1 2024, down 56.75% quarter-over-quarter from 1593000.0 in Q4 2023.
Bio-Techne (TECH) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends
Bio-Techne's Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 689000.0 for Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 689,000.00 |
| Mar 31, 2024 | 689,000.00 |
| Dec 31, 2023 | 1.59 Mn |
| Dec 31, 2023 | 1.59 Mn |